May 29, 2018
–Study suggests that novel oral formulation of edaravone improves bioavailability while remaining well tolerated– Rotterdam, The Netherlands, May 29th2018 – Treeway, a biotech company developing therapies against amyotrophic lateral sclerosis (ALS), today announced...
